{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T22:54:42Z","timestamp":1792364082640,"version":"4.4.0"},"reference-count":25,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>A 65-year-old man with history of urothelial carcinoma of the bladder developed dermatomyositis at the time of metastatic disease progression. This temporal association supports a likely paraneoplastic mechanism and highlights the importance of reassessing for disease progression in patients with urothelial carcinoma who develop new-onset dermatomyositis. Early recognition may facilitate timely oncologic evaluation and multidisciplinary management.<\/jats:p>","DOI":"10.3390\/curroncol33030176","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:44:41Z","timestamp":1773999881000},"page":"176","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dermatomyositis as a Paraneoplastic Syndrome of Metastatic Urothelial Carcinoma"],"prefix":"10.3390","volume":"33","author":[{"given":"Amn","family":"Marwaha","sequence":"first","affiliation":[{"name":"Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Sambhi","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada"},{"name":"Verspeeten Family Cancer Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7195-8246","authenticated-orcid":false,"given":"Ricardo","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry, Western University, London, ON N6A 5C1, Canada"},{"name":"Division of Medical Oncology, Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada"},{"name":"Verspeeten Family Cancer Centre, London Health Sciences Centre, London, ON N6A 5W9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","article-title":"Dermatomyositis: Clinical features and pathogenesis","volume":"82","author":"DeWane","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/acr.24786","article-title":"Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-Based Cohort Study","volume":"75","author":"Kronzer","year":"2022","journal-title":"Arthritis Care Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.3346\/jkms.2019.34.e55","article-title":"Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: A Nationwide Population-based Study","volume":"34","author":"Cho","year":"2019","journal-title":"J. Korean Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jamadermatol.2022.3112","article-title":"Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans","volume":"158","author":"Bolender","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"16444","DOI":"10.1038\/s41598-023-43880-7","article-title":"Incidence and prevalence, and medication use among adults living with dermatomyositis: An Alberta, Canada population-based cohort study","volume":"13","author":"Osman","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40257-015-0120-1","article-title":"Cancer Risk in Dermatomyositis: A Meta-Analysis of Cohort Studies","volume":"16","author":"Olazagasti","year":"2015","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1203475416665601","article-title":"Risk of malignancy in dermatomyositis and polymyositis: A systematic review and meta-analysis","volume":"21","author":"Qiang","year":"2017","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrrheum.2014.138","article-title":"Paraneoplastic syndromes in rheumatology","volume":"10","author":"Manger","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e9639","DOI":"10.1097\/MD.0000000000009639","article-title":"Evidence supports blind screening for internal malignancy in dermatomyositis: Data from 2 large US dermatology cohorts","volume":"97","author":"Leatham","year":"2018","journal-title":"Medicine"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","article-title":"International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: An International Myositis Assessment and Clinical Studies Group (IMACS) initiative","volume":"19","author":"Oldroyd","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Sabat\u00e9-Ortega, J., Bujons-Buscarons, E., Fina-Planas, C., Vilanova-Anducas, N., Vidal-Sarr\u00f3, N., and Sala-Gonz\u00e1lez, N. (2023). Paraneoplastic dermatomyositis associated with urothelial cancer: Report of a case and systematic review of the literature. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1223627"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ad.2013.11.007","article-title":"Paraneoplastic Dermatomyositis: A Study of 12 Cases","volume":"105","author":"Requena","year":"2014","journal-title":"Actas Dermo-Sifiliogr."},{"key":"ref_13","first-page":"815","article-title":"A Rare Paraneoplastic Dermatomyositis in Bladder Cancer with Fatal Outcome","volume":"10","author":"Xu","year":"2013","journal-title":"Urol. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0953-6205(03)90012-4","article-title":"Dermatomyositis and transitional cell carcinoma of the bladder: A rare paraneoplastic syndrome associated with tumor recurrence","volume":"14","year":"2003","journal-title":"Eur. J. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/0961203306071923","article-title":"Paraneoplastic dermatomyositis associated with bladder cancer","volume":"15","author":"Sabio","year":"2006","journal-title":"Lupus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/00007611-200093050-00009","article-title":"Fatal Bladder Cancer and Dermatomyositis","volume":"93","author":"Federman","year":"2000","journal-title":"South Med. J."},{"key":"ref_17","first-page":"50","article-title":"Case Report Dermatomyositis in Association with Transitional Cell Carcinoma of the Bladder Clinical Oncology","volume":"13","author":"Robinson","year":"2001","journal-title":"Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103375","DOI":"10.1016\/j.autrev.2023.103375","article-title":"Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature","volume":"22","author":"Guerra","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1017\/cjn.2023.238","article-title":"Dermatomyositis Immunosuppression in Bacillus Calmette-Guerin-Treated Urothelial Cancer","volume":"51","author":"Dimond","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.2147\/JIR.S480744","article-title":"Analysis of the Potential Link Between Dermatomyositis and Cancer","volume":"17","author":"Guo","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_21","first-page":"OC04","article-title":"Study of adverse effect profile of parenteral zoledronic acid in female patients with osteoporosis","volume":"10","author":"Kotian","year":"2016","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s00198-021-06021-2","article-title":"Diffuse adverse cutaneous reactions induced by zoledronic acid administration: A case report: Eruptions cutan\u00e9es diffuses induites par l\u2019administration de l\u2019acide zol\u00e9dronique","volume":"32","author":"Nassar","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2230.2011.04198.x","article-title":"Possible zoledronic acid-induced dermatomyositis","volume":"37","author":"Apalla","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1111\/j.1440-0960.2011.00771.x","article-title":"Drug-induced dermatomyositis after zoledronic acid","volume":"53","author":"Tong","year":"2012","journal-title":"Australas. J. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/3\/176\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:26:32Z","timestamp":1774002392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/3\/176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["curroncol33030176"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33030176","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}